Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CHMP recommends approval of UCB’s Bimzelx for plaque psoriasis

pharmatimesJune 29, 2021

Tag: CHMP , UCB , Bimzelx , plaque psoriasis , IL-17A

PharmaSources Customer Service